Patents Assigned to RD BIOMED LIMITED
  • Inhibition of pancreatic lipase
    Patent number: 9999632
    Abstract: The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: June 19, 2018
    Assignees: RD Biomed Limited, University of Newcastle upon Tyne
    Inventors: Johnathan Craig Richardson, Peter William Dettmar, Matthew David Wilcox, Iain Andrew Brownlee, Jeffrey Peter Pearson
  • Inhibition of pancreatic lipase
    Patent number: 9402858
    Abstract: The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
    Type: Grant
    Filed: November 25, 2010
    Date of Patent: August 2, 2016
    Assignees: RD Biomed Limited, University of Newcastle Upon Tyne
    Inventors: Johnathan Craig Richardson, Peter William Dettmar, Matthew David Wilcox, Iain Andrew Brownlee, Jeffrey Peter Pearson
  • INHIBITION OF PANCREATIC LIPASE
    Publication number: 20120302521
    Abstract: The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
    Type: Application
    Filed: November 25, 2010
    Publication date: November 29, 2012
    Applicants: UNIVERSITY OF NEWCASTLE UPON TYNE, RD BIOMED LIMITED
    Inventors: Johnathan Craig Richardson, Peter William Dettmar, Matthew David Wilcox, Iain Andrew Brownlee, Jeffrey Peter Pearson